MARAVAI LIFESCIENCES HLDGS-A (MRVI)

US56600D1072 - Common Stock

7.415  -0.2 (-2.56%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
799.2M
181.31%		883M
10.49%		288.945M
-67.28%		277.57M
-3.94%		N/A
EBITDA
YoY % growth
568.1M
348.38%		606.1M
6.69%		15.072M
-97.51%		64.035M
324.86%		N/A
EBIT
YoY % growth
543.4M
438.55%		574.2M
5.67%		-25.182M
-104.39%		16.344M
164.90%
Operating Margin
67.99%65.03%-8.72%5.89%N/A
EPS
YoY % growth
1.591.80
13.21%		0.03
-98.33%		-0.02
-161.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.03
-188.40%
Revenue
Q2Q % growth		61.761M
-21.82%
EBITDA
Q2Q % growth		9.22M
EBIT
Q2Q % growth		-2.445M
-197.82%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.01
-97.14%		-0.010.02182.94%
Q3 2023
Q2Q % growth		 -0.01
-102.70%		0.01-0.02-254.15%
Q2 2023
Q2Q % growth		 0.00
-100.00%		0.01-0.01-100.00%
Q1 2023
Q2Q % growth		 0.03
-94.44%		0.04-0.01-18.86%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 74.141M
-63.78%		65.667M8.474M12.90%
Q3 2023
Q2Q % growth		 66.9M
-65.03%		77.034M-10.134M-13.16%
Q2 2023
Q2Q % growth		 68.9M
-71.61%		72.548M-3.648M-5.03%
Q1 2023
Q2Q % growth		 79M
-67.66%		81.315M-2.315M-2.85%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -809.09% 0% -134.48%
Revenue0% 3.4% 0% 3.54%